Vitarich Corp., a publicly listed company, has entered into a strategic partnership with French genetics firm Novogen to provide local farmers with low-cost, high-yield chickens. This collaboration aims to increase egg production and offer a complete solution to Philippine poultry farmers by combining Novogen’s advanced genetics with Vitarich’s expertise in animal nutrition.
Ricardo Manuel Sarmiento, Vitarich president and CEO, highlighted the commercial significance of the partnership during a press event in Pampanga, noting that the use of Novogen’s “White” breed—capable of producing up to 470 eggs per hen over a 100-week cycle—would enhance the overall efficiency of egg production in the country.
“The Novogen White offers more egg output, better feed conversion, and stronger eggshells, which translates into lower costs and higher productivity for farmers, ultimately leading to increased profitability,” Sarmiento explained.
The partnership is seen as a potential “cash cow” for Vitarich, combining Novogen’s advanced breeding technology with Vitarich’s established feed products, creating a unique value proposition for the agricultural sector.
Vitarich, which celebrates its 75th anniversary this year, has seen a significant improvement in performance, with 2024 being its most successful year yet. Sarmiento anticipates even stronger results in 2025, with the first two months of the year already marking record-breaking figures.
Looking ahead, Sarmiento confirmed that Vitarich will expand into the ready-to-eat and ready-to-cook food segments with at least two new product launches planned for 2025, further diversifying its offerings to the local market.
